ArticleCancer science2026

Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI-Platinum Therapy (WJOG14120L).

Hiroshige Yoshioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.